Comorbidities, Coinfections, & Complications
Active Resources: 31
Online and Self-Paced Learning
-
2/5/2019
-
12/7/2016
-
11/16/2016
-
10/26/2016
-
10/19/2016
-
10/12/2016
Webinar Recordings
-
11/15/2018
-
11/8/2018
-
3/21/2018
-
12/11/2014
-
9/4/2014
Patient Information
-
5/31/2018
Toolkits
-
3/29/2018
-
6/2/2015
-
5/29/2015
-
8/27/2014
Articles & Bibliographies
-
11/15/2017
-
8/1/2017
Curricula
-
9/15/2017
Self-Study Materials
-
2/1/2017
Reports
-
1/1/2017
-
8/27/2015
-
7/4/2014
Manuals
-
10/25/2016
Slide Sets
-
5/10/2016
-
5/19/2015
Videos
-
12/29/2015
-
4/1/2015
-
7/31/2014
Coinfection Guidelines (Hep, TB, STIs)
-
12/1/2015
Primary Care Guidelines
-
11/9/2015
Archive Resources: 13
Webinar Recordings
-
4/7/2015
-
3/3/2015
Image Library
-
1/31/2014
OIs & Complications Guidelines
-
11/6/2013 (reviewed: 12/15/2016)
-
5/7/2013 (reviewed: 5/10/2016)
Reports
-
7/15/2013
Slide Sets
-
6/12/2012
-
12/1/2010
-
1/1/2006
Self-Study Materials
-
3/1/2010
-
1/1/2010
Charts, Tables & Posters
-
1/1/2008
Fact Sheets
-
1/1/2006
Articles: 2
-
HIV and Heart Disease – NIH Explores the Connection
HIV-positive men and women can now live longer than ever before. A 2013 study found that a newly diagnosed 20-year-old on effective antiretroviral therapy (ART) can expect to live into their 70s, a lifespan only slightly lower than in people without HIV.[1] While this is great news, physicians...
-
Use of Dolutegravir in Dialysis
Dolutegravir has several characteristics that, in theory, suggest it will not be significantly removed by dialysis: It has a large apparent volume of distribution (17.4 L) and is highly protein bound (98.9%). A small study of 5 HIV-infected patients with end-stage renal disease undergoing...
| Day | Title |
|---|---|
|
4/11 |
|
|
4/14 |
|
|
4/17 |
|
|
5/30 |
|
|
7/25 |